Direct-acting antivirals for paediatric HCV: we got there

Sokal, Etienne

doi:10.1038/nrgastro.2017.92

Direct-acting antivirals for paediatric HCV: we got there

Sokal, Etienne

(2017) Nature Reviews Gastroenterology & Hepatology — Vol. 14, n° 8, p. 452-453 (2017)

Files

No attached file found for this publication.

Details

Authors

Sokal, EtienneUCLouvain
Author

Abstract

In a new report, adolescents with genotype 2 or 3 HCV infection who were given sofosbuvir and ribavirin showed a near 100% sustained virologic response. This study is the beginning of a new wave of treatments for paediatric HCV infection, forming part of a global strategy to eradicate viral hepatitis.

Affiliations

UCLouvain(SLuc) Service de gastro-entérologie et hépatologie pédiatrique
UCLouvainSSS/IREC/PEDI - Pôle de Pédiatrie

Citations

APA
Chicago
FWB

Sokal, E. (2017). Direct-acting antivirals for paediatric HCV: we got there. Nature Reviews Gastroenterology & Hepatology, 14(8), 452-453. https://doi.org/10.1038/nrgastro.2017.92 (Original work published 2017)